Olaplex Q4 Sales Up 4.3% to $105.1M as Loss Widens; Hold Target $1.85
Olaplex’s Q4 net sales rose 4.3% to $105.1 million, driven by an 18.9% Professional-channel boost and 6.6% DTC gains, while net loss widened to $13.1 million from $8.8 million. FY25 sales held at $423.0 million with a $9.3 million loss, and seven brokers set a $1.85 average target rating Olaplex shares as Hold.
1. Q4 Financial Performance
In Q4 2025, Olaplex reported net sales of $105.1 million, up 4.3% year-over-year, driven by an 18.9% increase in Professional and 6.6% growth in direct-to-consumer channels, while specialty retail sales fell 14.5%. Gross profit margin expanded to 68.0%, but net loss grew to $13.1 million from $8.8 million.
2. Full-Year 2025 Results
For fiscal 2025, net sales were flat at $423.0 million, with Professional channel revenue up 5.5% offset by an 8.3% drop in specialty retail. The company swung to a $9.3 million net loss from a $19.5 million profit in 2024, as SG&A expenses rose 33.8%.
3. Analyst Consensus Target
Seven brokerages assign an average price target of $1.85 on Olaplex shares with a Hold consensus, reflecting mixed sell, hold and buy views among analysts.